Publications by authors named "Yoichi Yano"

Claim this Profile
M
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Hiroshi Isoda, Yuichi Honma, Yoichi Yano

Hepatol Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Yoichi Yano

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Yoichi Yano

Hepatol Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis.
Kota Takaki, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Yuki Zaizen

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
Yuki Zaizen, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Kota Takaki

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Yoichi Yano

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yoichi Yano

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma.
Masahito Nakano, Masatoshi Tanaka, Ryoko Kuromatsu, Hiroaki Nagamatsu, Kenji Sakata, Yoichi Yano

Oncology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.
Kazuta Fukumori, Yoichi Yano, Eiji Ando, Shuji Sumie, Kotoro Kuwaki

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of chronic hepatitis C virus-related advanced hepatocelluar carcinoma surviving more than 8 years].
Kazuta Fukumori, Yoichi Yano, Koutaro Kuwaki, Shuji Sumie, Eiji Ando

Nihon Shokakibyo Gakkai Zasshi· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Yoichi Yano, Fumihiko Yamashita, Kotaro Kuwaki, Kazuta Fukumori, Osamu Kato

Liver Int· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial spontaneous regression of hepatocellular carcinoma: a case with high concentrations of serum lens culinaris agglutinin-reactive alpha fetoprotein.
Yoichi Yano, Fumihiko Yamashita, Kotaro Kuwaki, Kazuta Fukumori, Osamu Kato

Kurume Med J· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Shuji Sumie, Fumihiko Yamashita, Eiji Ando, Masatoshi Tanaka, Yoichi Yano

AJR Am J Roentgenol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus-related hepatocellular carcinoma.
Yoichi Yano, Fumihiko Yamashita, Shuji Sumie, Kotaro Kuwaki, Hiroshi Yamamoto

Liver Int· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
Eiji Ando, Masatoshi Tanaka, Fumihiko Yamashita, Ryoko Kuromatsu, Akio Takada, Yoichi Yano

Eur J Gastroenterol Hepatol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of advanced hepatocelluar carcinoma achieving a complete response following the hepatic arterial infusion chemotherapy and subsequent lipiodolization].
Kazuta Fukumori, Eiji Ando, Fumihiko Yamashita, Masatoshi Tanaka, Syuji Sumie, Yoichi Yano

Nihon Shokakibyo Gakkai Zasshi· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
Eiji Ando, Masatoshi Tanaka, Fumihiko Yamashita, Ryoko Kuromatsu, Shigeru Yutani, Yoichi Yano

Cancer· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yoichi Yano, Fumihiko Yamashita, Shuji Sumie, Eiji Ando, Kazuta Fukumori

Am J Gastroenterol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis